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Abstract
The strength of the rat as a model organism lies in its utility in pharmacology,
biochemistry and physiology research. Data resulting from such studies is difﬁcult
to represent in databases and the creation of user-friendly data mining tools has
proved difﬁcult. The Rat Genome Database has developed a comprehensive ontology-
based data structure and annotation system to integrate physiological data along with
environmental and experimental factors, as well as genetic and genomic information.
RGD uses multiple ontologies to integrate complex biological information from the
molecular level to the whole organism, and to develop data mining and presentation
tools. This approach allows RGD to indicate not only the phenotypes seen in a strain
but also the speciﬁc values under each diet and atmospheric condition, as well as
gender differences. Harnessing the power of ontologies in this way allows the user
to gather and ﬁlter data in a customized fashion, so that a researcher can retrieve
all phenotype readings for which a high hypoxia is a factor. Utilizing the same data
structure for expression data, pathways and biological processes, RGD will provide
a comprehensive research platform which allows users to investigate the conditions
under which biological processes are altered and to elucidate the mechanisms of
disease. Copyright  2006 John Wiley & Sons, Ltd.
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Introduction
Initially, the Rat Genome Database (RGD) used
ontologies to provide a simple framework for clas-
sifying, representing and navigating across gene,
phenotype and disease information to link genomic
data to function and disease (Ashburner and Lewis,
2002; Stevens et al., 2000) and as a means of
providing a view of biological information in
the context of the genome. RGD implemented
four ontologies: Gene Ontology (GO), Mammalian
Phenotype Ontology (MP), Disease Ontology (DO)
a n daP athWay ontology (PW). The MP was
initially developed at Mouse Genome Informat-
ics (Smith et al., 2005). The disease ontology
was adapted from the Medical Subject Headings
(MeSH; Nelson et al., 2001) and the pathway
ontology was developed at RGD in order to inte-
grate data from existing pathway databases, such
as the Kyoto Encyclopedia of Genes and Genomes
(Kanehisa, 2002), REACTOME (Joshi-Tope et al.,
2005), GenMapDB (Dahlquist et al., 2002) and the
Biomolecular Interaction Database (Bader et al.,
2003), as well as pathway data found in the lit-
erature. It also includes ‘altered pathway’ terms
to allow for the representation of pathways whose
events or interactions are altered by genetic or envi-
ronmental factors.
Ontology annotations were also used in tools at
RGD to provide a view of biological information
in the context of the genome. Such tools include
the GViewer (Figure 1), which provides a genome-
wide view of the genes and QTLs related to a single
or multiple ontology query, and GBrowse, which
provides ontology tracks showing gene function,
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Figure 1. Genome viewer tool
pathway, disease and phenotype information in the
context of the genome.
For the more complex data generated by much of
the rat research community, the simple annotations
provided by single ontologies are insufﬁcient. They
do not answer questions about the conditions under
which the biological phenomena take place or what
factors could inhibit or modify them. They also
do not provide a mechanism for relating disparate
types of biological information to allow researchers
to elucidate patterns or mechanisms involved in
disease. Thus, RGD developed a structure that
would allow the integration of multiple ontology
annotations, as well as qualiﬁers and actual values,
into a single record.
Methods
Two major changes were made to the existing
ontology data structure at RGD. The ﬁrst were
additional ﬁelds added to the primary annotation
table (Full Annot Table in Figure 2). The existing
Full Annot table was modelled after that used by
many model organism databases to store GO data.
This table included such ﬁelds as ontology term,
term ID, aspect (or identiﬁer for ontology used),
notes, object symbol and ID (referring to genetic
or genomic object, such as gene and its associated
database ID). To accommodate the information
necessary for more complex data, additional ﬁelds
were added to the Full Annot table. These included
value for actual phenotype values, as well as
expression values; duration, to indicate the time
frame of treatments or conditions; qualiﬁer, which
provides ﬂexibility for adding such information as
resistance or susceptibility for disease or induced
phenotype terms; and a number of statistics ﬁelds.
The next area of change included the creation of
two additional tables for assay and protocol infor-
mation and a unique key consisting of the term
key, reference ID, evidence code, RGD ID and
experiment ID. The relationships among multiple
ontology annotations and values for a single record
are achieved through an Experiment/Assay table
(situated below the Full Annot table in Figure 2).
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Figure 2. Table structure for multiple ontogenies
Through this table, an annotation incorporating a
MP ontology term (decreased eosinophil count)
and ID, value, evidence code, and reference can
be linked to an annotation with an Environmental
Factor Ontology term for diet (decreased sodium
content), value and units, and these can be linked
to another annotation including an Environmental
Factor Ontology term for atmosphere (decreased
oxygen), value and units, and ﬁnally to a fourth
annotation including a Genetic Factor Ontology
term (female) to create a composite annotation indi-
cating that, for the LE/BluGill strain, a decreased
eosinophil count (0.0089E3) was found under the
conditions of a decreased sodium diet (0.4%) and
decreased oxygen (12%) in females (Figure 3).
Such a composite annotation can be associated
with the genomic and genetic elements in RGD,
such as genes or mapped phenotypes (Quantita-
tive Trait Loci) or as in this case, a strain. A
composite annotation can also stand alone as an
experimental record relating phenotypes, drugs,
diseases, pathways and other physiological phe-
nomena to each other. This is a unique feature
in the structure, which allows the annotation of
a concept represented in one ontology to a con-
cept represented in a second ontology. A curator
may annotate a disease (Alagille Syndrome) to a
pathway (Notch Signalling) and indicate the asso-
ciated mutation in a single record (Jag 1, multi-
ple locations), as illustrated in Figure 3. Ontolo-
gies for rat anatomy, cell types, developmental
stages, drugs, genetic factors and environmental
conditions, as well as qualiﬁers added to the sys-
tem, facilitate integration and representation of
complex phenotype, disease, expression, pathway
and pharmacological data. Phenotype annotations
will thus include not only the phenotype ontology
term, but also the actual value and the experi-
mental and genetic factors involved. The use of
the Experiment/Assay Data Object allows RGD
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Figure 3. Sample records using multiple ontogeny annotations
to include pharmacological and physiological data
that is not tied to a speciﬁc genetic or genomic
object. The protocol table is designed to hold addi-
tional information required in the MIAME stan-
dards for expression data and for storing complete
phenotype protocols.
Because of the ﬂexibility of the composite anno-
tation records, data mining tools can be designed
to allow researchers to search for data based on
any of the ontologies used. The Phenotype Search
and Analysis Tool (Figure 4) allows the user to
customize datasets through a series of ﬁltering
choices presented to the user, based on a previ-
ous selection and data availability. Thus, a user
selecting a broad trait area is presented with a
list of associated phenotypes. Based on the pheno-
type(s) selected, the user is presented with choices
of experimental conditions for which there is data
available. Because of the ontological structure of
the data for all areas, users have the option to
sort data by broad or narrow classiﬁcations as
they wish. A user can ﬁlter phenotype data by all
diet conditions, only those with changed mineral
content or more narrowly by speciﬁc percentage
of sodium content. Tools can be designed in a
modular fashion to allow users to approach data as
they wish. Rather than beginning with a phenotype,
a user will be able to begin with an experimen-
tal condition, such as high salt content diet, and
then be presented with all phenotypes associated
with the condition and for which there is data in
the database and proceed to ﬁlter data by other
ﬁelds.
RGD has developed an infrastructure to efﬁ-
ciently access ontology annotations in the database
for its Quick and Advanced search tools and its
GViewer tool. This infrastructure will also be
used to query multiple ontology annotations. The
method used to query the data is based on PL/SQL
functions and procedures in an Oracle 9i database.
Matching annotations to terms or descendants of
terms are selected and stored in temporary tables in
the database. The experimental IDs of these match-
ing annotations are then used to query the database
for associated annotations from any other ontology.
The iterative querying enables the mining of the
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Figure 4. Phenotype data-mining tool
data by selecting parameters from multiple ontolo-
gies that are co-associated. The tools are designed
in Java JDK 1.3 and graphical reports use SVG
technologies.
Results and Discussion
Because the rat is used by a diverse commu-
nity involved in physiological and disease research,
investigators are often unsure of the best model to
use to study particular phenotypes. By integrating
environmental and genetic factors into our model,
as well as the inclusion of actual values, RGD
can provide phenotype analysis tools to aid the
researcher in choosing appropriate models based on
the phenotype and conditions of interest. The mul-
tiple ontology data structure and annotation system
supplies the user with an instant view of the pro-
cesses, phenotypes, pathway(s) and environmental
and genetic factors pertinent to a given disease.
The database infrastructure is already shared by
several tools and RGD will integrate the multi-
ple ontology structure in a number of tools, which
will facilitate navigation across data for complex
queries. The design and implementation of addi-
tional sophisticated data-mining tools for experi-
mental data will allow investigators to more easily
search for the answer to questions such as: ‘Under
what conditions is an increase in the severity of a
phenotype or a change in the expression of a gene
or mutant gene observed?’; ‘Are diseases associ-
ated with the same pathway different in their man-
ifestations because of differences in the nature of
the alterations?’; ‘Is, for instance, Notch signalling
pathway compromised because the promoters of
target gene are mutated, the receptors are not prop-
erly modiﬁed or because mutations in either recep-
tor or ligand interfere with the normal activity?’;
‘Are the manifold malformations (heart, eye, ver-
tebral column) of the Alagille syndrome the result
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of the various instances of Jag1 ligand mutations,
scattered across the entire gene?’; ‘Are individu-
als affected with CADASIL condition more sensi-
tive to environmental stress because the mutations
within the Notch3 receptor irrevocably compromise
a three-disulphide bond pattern and, for this matter,
its structural integrity?’.
It is precisely the ability to navigate between and
link instances of expression, genetic and environ-
mental attributes, where ontology annotations could
help researchers unthread the interplay between
genes, mutations and environment that underlie
complex human diseases.
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